PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

Danny Rischin, David R. Spigel, Douglas Adkins, Richard Wein, Susanne Arnold, Nimit Singhal, Oliver Lee, Swami Murugappan

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Medicine & Life Sciences